CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-01 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −8,027 | $140.20 | $1.1M | 201,999 |
| 2025-04-01 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −4,022 | $141.11 | $568K | 197,977 |
| 2025-04-01 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −1,334 | $142.28 | $190K | 196,643 |
| 2025-03-31 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −2,494 | $138.41 | $345K | 75,625 |
| 2025-03-31 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −68 | $138.36 | $9K | 75,557 |
| 2025-03-31 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −9,311 | $138.41 | $1.3M | 212,793 |
| 2025-03-31 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −252 | $138.42 | $35K | 212,541 |
| 2025-03-31 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −1,367 | $138.41 | $189K | 225,318 |
| 2025-03-31 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −37 | $138.39 | $5K | 225,281 |
| 2025-03-28 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +6,250 | 78,119 | ||
| 2025-03-28 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit 10b5-1 | −6,250 | 6,250 | ||
| 2025-03-28 | Chapman Steven Leonard CEO AND PRESIDENT | Option exercise 10b5-1 | +18,750 | 222,104 | ||
| 2025-03-28 | Chapman Steven Leonard CEO AND PRESIDENT | Option exercise · Restricted Stock Unit 10b5-1 | −18,750 | 18,750 | ||
| 2025-03-28 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Option exercise 10b5-1 | +2,500 | 226,685 | ||
| 2025-03-28 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Option exercise · Restricted Stock Unit 10b5-1 | −2,500 | 2,500 | ||
| 2025-03-28 | Bertagnolli Monica Director | Grant or award | +2,877 | 2,877 | ||
| 2025-03-18 | Sheena Jonathan Director | Sale 10b5-1 | −2,017 | $145.17 | $293K | 259,002 |
| 2025-03-18 | Sheena Jonathan Director | Sale 10b5-1 | −53 | $145.60 | $8K | 258,949 |
| 2025-03-18 | Sheena Jonathan Director | Sale 10b5-1 | −630 | $146.81 | $92K | 258,319 |
| 2025-03-18 | Sheena Jonathan Director | Sale 10b5-1 | −1,070 | $145.09 | $155K | 42,212 |
Page 51 of 55 · 1,093 trades